{"id":"https://openalex.org/W2039609199","doi":"https://doi.org/10.1016/s0301-472x(99)00089-2","title":"Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu","display_name":"Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu","alternate_titles":[],"publication_year":1999,"publication_date":"1999-10-01","ids":{"openalex":"https://openalex.org/W2039609199","doi":"https://doi.org/10.1016/s0301-472x(99)00089-2","mag":"2039609199","pmid":"https://pubmed.ncbi.nlm.nih.gov/10517495"},"language":"en","primary_location":{"id":"doi:10.1016/s0301-472x(99)00089-2","doi":"https://doi.org/10.1016/s0301-472x(99)00089-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0301-472x(99)00089-2","pdf_url":"http://www.exphem.org/article/S0301472X99000892/pdf","source":{"id":"https://openalex.org/S72188638","display_name":"Experimental Hematology","issn_l":"0301-472X","issn":["0301-472X","1873-2399"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental Hematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2039609199"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.exphem.org/article/S0301472X99000892/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101974554","display_name":"Sarah Cooley","orcid":"https://orcid.org/0000-0001-8953-6730","observed_orcids":["https://orcid.org/0000-0001-8953-6730"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sarah Cooley","raw_affiliation_strings":["Department of Medicine, University of Minnesota Cancer Center, Minneapolis 55455, USA","Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center, Minneapolis, MN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Minnesota Cancer Center, Minneapolis 55455, USA","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]},{"raw_affiliation_string":"Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center, Minneapolis, MN USA","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084230861","display_name":"Linda J. Burns","orcid":"https://orcid.org/0000-0003-1341-4424","observed_orcids":["https://orcid.org/0000-0003-1341-4424"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Linda J Burns","raw_affiliation_strings":["Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center, Minneapolis, MN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center, Minneapolis, MN USA","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032051083","display_name":"Tanya L. Repka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tanya Repka","raw_affiliation_strings":["Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center, Minneapolis, MN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center, Minneapolis, MN USA","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027151969","display_name":"Jeffrey S. Miller","orcid":"https://orcid.org/0000-0002-0339-4944","observed_orcids":["https://orcid.org/0000-0002-0339-4944"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jeffrey S Miller","raw_affiliation_strings":["Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center, Minneapolis, MN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center, Minneapolis, MN USA","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5027151969"],"corresponding_institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"],"apc_list":{"value":3250,"currency":"USD","value_usd":3250},"apc_paid":{"value":3250,"currency":"USD","value_usd":3250},"fwci":1.4517,"has_fulltext":true,"cited_by_count":257,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.80571505,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"27","issue":"10","first_page":"1533","last_page":"1541"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9620000123977661},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.972000002861023},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cd58","display_name":"CD58","score":0.7590000033378601},{"id":"https://openalex.org/keywords/lfa-3","display_name":"LFA-3","score":0.8100000023841858},{"id":"https://openalex.org/keywords/her2-neu","display_name":"HER2/neu","score":0.8479999899864197},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/icam-1","display_name":"ICAM-1","score":0.8889999985694885},{"id":"https://openalex.org/keywords/cd18","display_name":"CD18","score":0.9350000023841858},{"id":"https://openalex.org/keywords/cd2","display_name":"CD2","score":0.9779999852180481},{"id":"https://openalex.org/keywords/fc-gamma-receptor-iii","display_name":"Fc gamma receptor III","score":0.7289999723434448},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.8640000224113464},{"id":"https://openalex.org/keywords/cell-adhesion-molecules","display_name":"adhesion molecules","score":0.5220000147819519},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.9113888740539551},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.7527375221252441},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5808002352714539},{"id":"https://openalex.org/C2778102761","wikidata":"https://www.wikidata.org/wiki/Q332181","display_name":"Natural killer cell","level":4,"score":0.534701943397522},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5334762334823608},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4959331452846527},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.461692214012146},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.45946595072746277},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4274420142173767},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.41154801845550537},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34648171067237854},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.2903335988521576},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23589220643043518},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.17208856344223022},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06235119700431824},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003601","descriptor_name":"Cytotoxicity Tests, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018799","descriptor_name":"Intercellular Adhesion Molecule-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018821","descriptor_name":"CD18 Antigens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018968","descriptor_name":"CD58 Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018968","descriptor_name":"CD58 Antigens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0301-472x(99)00089-2","doi":"https://doi.org/10.1016/s0301-472x(99)00089-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0301-472x(99)00089-2","pdf_url":"http://www.exphem.org/article/S0301472X99000892/pdf","source":{"id":"https://openalex.org/S72188638","display_name":"Experimental Hematology","issn_l":"0301-472X","issn":["0301-472X","1873-2399"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental Hematology","raw_type":"journal-article"},{"id":"pmid:10517495","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10517495","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental hematology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/s0301-472x(99)00089-2","doi":"https://doi.org/10.1016/s0301-472x(99)00089-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0301-472x(99)00089-2","pdf_url":"http://www.exphem.org/article/S0301472X99000892/pdf","source":{"id":"https://openalex.org/S72188638","display_name":"Experimental Hematology","issn_l":"0301-472X","issn":["0301-472X","1873-2399"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000908608","display_name":"Off-the-Shelf Immune Effector Cells for Hematological Malignancies","funder_award_id":"P01CA065493","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306095","display_name":"American Cancer Society","ror":"https://ror.org/02e463172"},{"id":"https://openalex.org/F4320306571","display_name":"American Society of Hematology","ror":"https://ror.org/02nw48b86"},{"id":"https://openalex.org/F4320309636","display_name":"University of Minnesota","ror":"https://ror.org/03grvy078"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2039609199.pdf","grobid_xml":"https://content.openalex.org/works/W2039609199.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W134727146","https://openalex.org/W175021650","https://openalex.org/W175201022","https://openalex.org/W201942322","https://openalex.org/W307339191","https://openalex.org/W1475256780","https://openalex.org/W1571069726","https://openalex.org/W1578064973","https://openalex.org/W1635322256","https://openalex.org/W1678686630","https://openalex.org/W1881816600","https://openalex.org/W1942361359","https://openalex.org/W1968193071","https://openalex.org/W1976128207","https://openalex.org/W1977353746","https://openalex.org/W1980459113","https://openalex.org/W1993030380","https://openalex.org/W1993261975","https://openalex.org/W2012316443","https://openalex.org/W2018452925","https://openalex.org/W2021406365","https://openalex.org/W2048281897","https://openalex.org/W2057312481","https://openalex.org/W2061097078","https://openalex.org/W2063831546","https://openalex.org/W2065064603","https://openalex.org/W2082117763","https://openalex.org/W2088589733","https://openalex.org/W2090639012","https://openalex.org/W2134664528","https://openalex.org/W2395694643","https://openalex.org/W2409157678","https://openalex.org/W2416089859","https://openalex.org/W4234355290"],"related_works":["https://openalex.org/W2083786790","https://openalex.org/W6992992757","https://openalex.org/W1534445344","https://openalex.org/W4313389567","https://openalex.org/W2588820636","https://openalex.org/W1788305820","https://openalex.org/W6983799442","https://openalex.org/W2048772193","https://openalex.org/W3176412723","https://openalex.org/W2187237560"],"abstract_inverted_index":{"Treatment":[0],"of":[1,16,57,65,92,110,158,181,231,245,251,264],"advanced":[2],"breast":[3,40,58,86,111,207,246,270],"cancer":[4,41,59,87,112,208,247,271],"with":[5,155],"autologous":[6],"stem":[7],"cell":[8,42,55,88,108,243],"transplantation":[9],"is":[10,47,114,117],"limited":[11],"by":[12,219],"a":[13,194,228],"high":[14],"probability":[15],"disease":[17],"relapse.":[18],"In":[19],"clinical":[20],"trials,":[21],"interleukin":[22],"2":[23],"(IL-2)":[24],"alone":[25],"can":[26,266],"expand":[27],"natural":[28],"killer":[29],"(NK)":[30],"cells":[31,70,104],"in":[32,81,241],"vivo":[33],"and":[34,95,116,124,147,174,259],"increase":[35,46],"their":[36],"cytotoxic":[37],"activity":[38],"against":[39,84,137,197,202],"lines,":[43],"but":[44,170],"this":[45,182],"modest.":[48],"Understanding":[49],"the":[50,179,204,252],"mechanisms":[51,238,263],"that":[52,97,153,236,249,260],"mediate":[53],"NK":[54,69,103,107,242],"lysis":[56,109,244],"targets":[60,113,253],"may":[61],"lead":[62],"to":[63,133,144,222,257,269],"improvements":[64],"current":[66],"immunotherapy":[67,268],"strategies.":[68],"from":[71],"normal":[72],"donors":[73],"or":[74,224],"patients":[75],"receiving":[76],"subcutaneous":[77],"IL-2":[78],"were":[79],"tested":[80],"cytotoxicity":[82,152,186],"assays":[83],"five":[85],"lines.":[89],"The":[90,160],"role":[91],"adhesion":[93],"molecules":[94],"antibodies":[96,221],"interact":[98],"through":[99,122],"Fc":[100],"receptors":[101],"on":[102,120,168,172],"was":[105,164,190,216],"explored.":[106],"variable":[115],"partially":[118],"dependent":[119,165],"recognition":[121],"ICAM-1":[123],"CD18.":[125],"While":[126],"blocking":[127,220],"CD2":[128,173,223],"slightly":[129],"decreased":[130],"cytotoxicity,":[131],"contrary":[132],"expectations,":[134],"an":[135,150],"antibody":[136,189,196],"CD58":[138,161,183,211],"(the":[139],"ligand":[140],"for":[141],"CD2),":[142],"failed":[143],"block":[145],"killing":[146,163],"instead":[148],"mediated":[149,199],"increased":[151],"correlated":[154],"target":[156,267],"density":[157],"CD58.":[159],"antibody-enhanced":[162],"not":[166],"only":[167],"FcRgammaIII":[169],"also":[171],"ICAM-1/CD18.":[175],"To":[176],"further":[177],"elucidate":[178],"mechanism":[180,230],"antibody-dependent":[184],"cellular":[185],"(ADCC),":[187],"another":[188],"tested.":[191],"Trastuzumab":[192],"(Herceptin),":[193],"humanized":[195],"HER2/neu,":[198],"potent":[200],"ADCC":[201,215,265],"all":[203],"HER2/neu":[205],"positive":[206],"targets.":[209],"Unlike":[210],"antibody-mediated":[212],"ADCC,":[213],"Herceptin":[214],"minimally":[217],"affected":[218],"ICAM-1/CD18,":[225],"which":[226],"suggests":[227],"different":[229],"action.":[232],"This":[233],"study":[234],"shows":[235],"multiple":[237],"are":[239,254],"involved":[240],"targets,":[248],"none":[250],"inherently":[255],"resistant":[256],"killing,":[258],"two":[261],"distinct":[262],"cells.":[272]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2039609199","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
